Are we over-treating 50,000 men each year? Could it be even more?
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: over-treatment, PSA, risk | 22 Comments »
Gen-Probe starts clinical trial of PCA3 test in USA
Posted on August 28, 2009 by Sitemaster
Gen-Probe announced yesterday that it has begun a clinical trial designed to seek U.S. regulatory approval of the PROGENSA® PCA3 assay.
Filed under: Diagnosis, Risk | Tagged: clinical trial, PCA3, Progensa | 5 Comments »
Partnership status and quality of life
Posted on August 28, 2009 by Sitemaster
Having high socioeconomic status AND being in a strong, positive, and supportive relationship may have improved the health-related quality of life (HRQOL) of men with localized prostate cancer, according to a recent study.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: HRQOL, partners, quality of life | 1 Comment »
Study shows massive drop in risk for diagnosis with more advanced forms of prostate cancer
Posted on August 28, 2009 by Sitemaster
Please note that this report has been modified from the original now that we have been able to obtain an actual copy of the full paper. According to a new report by Grace Lu-Yao and colleagues, published yesterday in the Journal of the National Cancer Institute, “Men with prostate cancer are being diagnosed at a [...]
Filed under: Diagnosis, Management, Risk | Tagged: advanced, risk | 1 Comment »
The cost of radical prostatectomy — should how it’s done affect the cost?
Posted on August 27, 2009 by Sitemaster
There is an interesting discussion brewing on the Medscape web site, where Dr. Gerald Chodak has posted a video discussion on whether the government (i.e., Medicare) should only reimburse for the lowest-cost alternative when it comes to radical prostatectomy. (You have to be a Medscape member to see this video and participate in the discussion, [...]
Filed under: Management, Treatment | Tagged: radical prostatectomy, reimburesment | Leave a Comment »
Hormone therapy, radiotherapy, and risk for cardiovascular mortality
Posted on August 27, 2009 by Sitemaster
An article in this week’s Journal of the American Medical Association has gained a great deal of media attention because it links hormone therapy in prostate cancer patients to a risk for death in patients with pre-existing cardiovascular disorders. The “New” Prostate Cancer InfoLink feels that it should emphasize that the outcomes reported in this study are [...]
Filed under: Management, Treatment | Tagged: cardiovascular, hormone therapy, mortality, radiation therapy, risk | Leave a Comment »
Radical prostatectomy — surgeons’ web sites get a pretty poor grade!
Posted on August 27, 2009 by Sitemaster
There is extensive promotion of the various forms of radical prostatectomy as a method for the treatment of prostate cancer. However, it would be fair to say that the supposed benefits of treatment are normally given a great deal more prominence than the very real risks.
Filed under: Management, Treatment | Tagged: erectile dysfunction, promotion, radical prostatectomy. web sites, RALP | 1 Comment »
Prostate cancer on “Larry King Live”
Posted on August 23, 2009 by Sitemaster
If you want to watch the discussion from Friday night on “Larry King Live” (with Michael Milken, John McEnroe, Colin Powell, Joe Torre, and others), just click on this link to CNN Video (and ignore the ad the precedes the program).
Filed under: Uncategorized | 2 Comments »
Positive surgical margins and robot-assisted laparoscopic prostatectomy
Posted on August 22, 2009 by Sitemaster
There has long been discussion over whether a lack of tactile sensation affects the likelihood of positive surgical margins (PSMs) in patients undergoing robot-assisted laparoscopic prostatectomy (RALP). A new single-institution cohort offers data on PSM rates in that institution’s most current 500 cases — with a specific emphasis on patients with clinically high-risk disease.
Filed under: Management, Treatment | Tagged: positive surgical margin, PSM, RALP, robot-assisted laparoscopic prostatectomy | 4 Comments »
5-year biochemical recurrence rates after first-line cryotherapy
Posted on August 22, 2009 by Sitemaster
A recent publication has correlated nadir post-cryoablation PSA levels (i.e., the lowest PSA level achieved by the patient after treatment) with long-term biochemical disease-free survival in a risk-stratified cohort of patients with prostate cancer treated with cryoablation.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical recurrence-free, cryoablation, cryotherapy, first line, survival | Leave a Comment »
What Gleason scores are telling us today
Posted on August 21, 2009 by Sitemaster
It has been known for a while that interpretation of pathological data, and the assignment and assignment of Gleason scores, today has changed from the way that such data were being interpreted 10 to 15 years ago.
Filed under: Management, Treatment | 5 Comments »
Prostate cancer news update: Friday, August 21, 2009
Posted on August 21, 2009 by Sitemaster
In today’s reports we note items related to: Whether add-back estrogen improves cognitive function in men on ADT Exercise and its impact on the side effects of ADT A new technique for delivering prostate cancer “vaccines” The potential of VEGF inhibitors in prostate cancer treatment
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapoy, cognitive function, electroporation, estrogen, exercise, vaccine, VEGF inhibitor | Leave a Comment »
Prostate cancer news reports: Wednesday, August 19
Posted on August 19, 2009 by Sitemaster
Today’s news reports address: Smoking and risk for prostate cancer Assessing risk for a positive second biopsy after a prior negative biopsy Smoking pot won’t cure your cancer but … Pemetrexed not effective as a single agent in CRPC patients after docetaxel failure
Filed under: Diagnosis, Drugs in development, Management, Prevention, Risk, Treatment, Uncategorized | Tagged: biopsy, canabis, castration-resistant prostate cancer, CPRC, pemetrexed, pot, risk, smoking | Leave a Comment »
Proton beam radiotherapy in the UK
Posted on August 19, 2009 by Sitemaster
Reports in the British media state that the UK’s Ministry of Health is committing to the broader availability of proton beam radiation therapy (PBRT) through the British National Health Service (NHS).
Filed under: Management, Treatment | Tagged: PBRT, proton beam radiation therapy, UK | 4 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site
